Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Effects of Erythropoietin on Neuronal Cell Death in Traumatic Brain Injury Patients

NCT00260052 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT00260052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00260052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Effects of Erythropoietin on Neuronal Cell Death in Traumatic Brain Injury Patients
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2/3
Overall status
Withdrawn
Start date
July 31, 2003
Completion date
January 31, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury